Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
NGO

National Comprehensive Cancer Network

Tracked across 11 events · 80 articles · First seen Apr 01, 2026 · Last active Sep 24, 2026

Sentiment
18
Attention
4
Events
11
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 60
Tech
Impact: The National Comprehensive Cancer Network hosted its 2026 Annual Conference, bringing together oncology professionals to discuss advancements in cancer care, research, and guidelines.
Apr 01, 2026 · 7 articles
2 20
Business
Impact: The National Comprehensive Cancer Network announced the selection of Nancy L. Lewis as its new Chief Scientific Officer, which is expected to advance its programs in clinical trials and cancer care.
Apr 09, 2026 · 7 articles
2 60
Tech
Impact: The National Comprehensive Cancer Network>>> (NCCN) has updated and expanded the availability of its Distress Thermometer and Problem List, a key tool for cancer care, making it accessible in over 70 languages. This enhances its global reach and impact on patient care.
May 20, 2026 · 8 articles
2 50
Tech
Impact: The National Comprehensive Cancer Network launched a new free email service to provide weekly updates on its NCCN Clinical Practice Guidelines in Oncology, aiming to improve access to current cancer treatment recommendations.
May 27, 2026 · 8 articles
2 0
Regulatory
The National Comprehensive Cancer Network published updated survey data on generic cancer medication shortages in the United States, based on responses from pharmacy directors and clinical leadership at its member institutions collected in late August…
Impact: NCCN published the survey data that anchors this event and leads advocacy through the End Cancer Drug Shortages Coalition. Its findings reinforce its policy influence but also highlight an unresolved systemic problem.
Sep 10, 2026 · 6 articles
0 10
Tech
The National Comprehensive Cancer Network (NCCN) participated in the bi-annual World Cancer Congress in China — Hong Kong, hosted by the Union for International Cancer Control (UICC). NCCN presented two original research abstracts. The first,…
Impact: NCCN is the central organizer and presenter of the research abstracts, enhancing its global reputation as a standard-setter in cancer care guidelines.
Sep 24, 2026 · 8 articles
4 0
Regulatory
Impact: The NCCN's Category 1 recommendation for Signatera MRD-guided adjuvant atezolizumab in bladder cancer guidelines adds clinical credibility and may influence adoption.
Aug 05, 2026 · 7 articles
4 0
Tech
Impact: The National Comprehensive Cancer Network's risk groups are used as a benchmark against which the Prolaris Biopsy Test's prognostic information is shown to add significant value.
Jul 02, 2026 · 6 articles
2 0
Regulatory
Natera announced that its Signatera test received regulatory approval from Japan's Japan — Pharmaceuticals and Medical Devices Agency as a companion diagnostic in muscle-invasive bladder cancer. The approval supports the use of Signatera to guide…
Impact: The NCCN published a Category 1 recommendation for MRD-guided adjuvant atezolizumab in bladder cancer, supporting adoption of Signatera-guided care.
Sep 22, 2026 · 6 articles
4 0
Business
Impact: NCCN Guidelines include Zegfrovy as a Category 2A subsequent therapy option.
Jul 14, 2026 · 8 articles
2 0
Tech
Apr 28, 2026 · 9 articles
ERGEN INTELLIGENCE
Track National Comprehensive Cancer Network live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.